News
-
-
PRESS RELEASE
HomeToGo releases the results of its Annual General Meeting 2024 with shareholders approving all agenda items by a very large majority
HomeToGo SE reports positive outcomes from its Annual General Meeting 2024, with shareholders approving all agenda items by a significant majority. Key leadership reflects on strong fiscal year 2023 and future plans -
-
PRESS RELEASE
HomeToGo previews end-to-end travel journey AI companion, Super AI Sunny, and announces enhancements in collaboration with Google Cloud's Vertex AI
HomeToGo unveils Super AI Sunny travel companion & announces collaboration with Google Cloud's Vertex AI to enhance AI-powered marketplace. New product enhancements launched -
-
PRESS RELEASE
HomeToGo reports strong Q1/24 performance: IFRS Revenues growth >60% YoY and fully on track to achieve 2024 goals. Introduction of new B2C and B2B business segment reporting
HomeToGo SE reports strong Q1/24 performance with IFRS Revenues growth >60% YoY, on track to achieve 2024 goals. New B2C and B2B segment reporting introduced -
-
PRESS RELEASE
HomeToGo to Announce First Quarter 2024 Financial Results on 14 May 2024
HomeToGo SE to announce first quarter 2024 financial results on 14 May 2024. CFO Steffen Schneider to present results in conference call at 10:00 am CEST, followed by Q&A session. Visit ir.hometogo.de for more info -
-
![Accesswire](/assets/images/accesswire-inline.png)
-
Southern Energy Corp. Announces Payment of Interest in-Kind to its 8% Convertible Unsecured Subordinated Debentures
-
APWG 2024 Cybercrime Research Conference Extends Submission Deadline to July 7
-
Product Creation Studio Partners With PatchClamp Medtech Inc. to Develop Revolutionary Dural Repair System
-
XS Financial Enters Into Definitive Agreement to Be Taken Private
-
TRU Engages Investor Relations Specialists HE Capital Markets
![EQS Group](/assets/images/eqs-group.png)
-
DEFENCE’S ARM-X ANTI-CANCER VACCINE INHIBITS GROWTH OF PRE-ESTABLISHED OVARIAN CANCER RESULTING IN COMPLETE RESPONSES IN TREATED ANIMALS
-
Agreement reached with iBusiness Funding to acquire Funding Circle’s US business
-
Cairn Homes Plc: Transaction in Own Shares
-
Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
-
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
![Les Echos](/assets/images/les-echos.png)
-
Signing of the share purchase agreement for the acquisition of a majority stake in Neoen by Brookfield from Impala and other shareholders and of a tender agreement between Brookfield and Bpifrance
-
Schneider Electric launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2031 for a nominal amount of €750 million and a concurrent repurchase of its outstanding OCEANEs due 2026
-
Gimv increases its stake in TINC – Gimv and Belfius conclude agreement in principle on the sale of the shares of Belfius Insurance in TINC
-
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2024
-
2023/2024 Third Quarter Sales